title: 5-Azacytidine (NSC 102816) in refractory germ cell tumors. A phase II trial of the Eastern Cooperative Oncology Group.
authors.affiliation: Indiana University Medical Center, Indianapolis.
authors.forename: B J
authors.initials: BJ
authors.lastname: Roth
authors.forename: P
authors.initials: P
authors.lastname: Elson
authors.forename: G W
authors.initials: GW
authors.lastname: Sledge
authors.forename: L H
authors.initials: LH
authors.lastname: Einhorn
authors.forename: D L
authors.initials: DL
authors.lastname: Trump
mesh_terms: D001374:Azacitidine / Q000627:therapeutic use* / Q000633:toxicity; D018237:Germinoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008479:Mediastinal Neoplasms / Q000188:drug therapy; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy
chemical_list: D001374:Azacitidine